RE: Praluent (Alirocumab)-Induced Renal Injury

Journal article

Open access

Peer reviewed

Robert Rosenson, Dominique Larrey, David Waters and Anders Olsson

Journal of Pharmacy Practice, Vol.31(2), pp.138-139

2018

PMCID: PMC5844452

PMID: 28974137

Abstract

rosuvastatin

alirocumab

acute renal injury

Antibodies, Monoclonal

Antibodies, Monoclonal, Humanized

Cholesterol, LDL

Humans

Kidney

url

Find in HALView

url

https://doi.org/10.1177/0897190017734429View

Published (Version of record) Open

1 Record Views

Title: RE: Praluent (Alirocumab)-Induced Renal Injury
Creators - without role: Robert Rosenson - Icahn School of Medicine at Mount Sinai
Dominique Larrey - Hôpital Saint Eloi
David Waters - San Francisco General Hospital
Anders Olsson - Linköping University
Publication Details: Journal of Pharmacy Practice, Vol.31(2), pp.138-139
Identifiers: 9942750709311
Academic Unit: Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
Language: English
Resource Type: Journal article
Local Fields: hal-03524332